Drug
BI 706321
BI 706321 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
200%(4 trials)
Terminated
2(50%)
Phase Distribution
Ph phase_1
3
75%
Ph phase_2
1
25%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Terminated2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
terminated250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_1
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT05183360
completedphase_1
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321
NCT03971695
completedphase_1
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood
NCT04714073
terminatedphase_2
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
NCT04978493
Clinical Trials (4)
Showing 4 of 4 trials
NCT05183360Phase 1
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT03971695Phase 1
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321
NCT04714073Phase 1
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood
NCT04978493Phase 2
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4